Recovery from skeletal fluorosis (an enigmatic, American case)

Journal of Bone and Mineral Research

Volumn 22, Issue 1, 2007, Pages 163-170

  Kurland, Etah S ^a,f   Schulman, Rifka C ^b   Zerwekh, Joseph E ^c   Reinus, William R ^d   Dempster, David W ^e,f   Whyte, Michael P ^g,h  

^a NewYork Presbyterian Hospital   (United States)

^b SUNY Downstate Medical Center   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d TEMPLE UNIVERSITY HOSPITAL   (United States)

^e HELEN HAYES HOSPITAL   (United States)

^f Columbia University ^*  (United States)

^g SHRINERS HOSPITAL FOR CHILDREN   (United States)

^h WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone densitometry; Bone histomorphometry; Bone turnover markers; Enthesopathy; Fluoride; Nephrolithiasis; Osteoarthritis; Osteosclerosis; Toothpaste

Indexed keywords

CREATININE; FLUORIDE; TETRACYCLINE; TOOTHPASTE;

ADULT; ARTICLE; BONE DISEASE; BONE MARROW BIOPSY; BONE RADIOGRAPHY; CALCULATION; CANCELLOUS BONE; CASE REPORT; CREATININE BLOOD LEVEL; DIAGNOSTIC IMAGING; DUAL ENERGY X RAY ABSORPTIOMETRY; ENTHESOPATHY; FEMUR NECK; FLUOROSIS; FOLLOW UP; HUMAN; IMAGE ANALYSIS; IMMOBILIZATION; LUMBAR SPINE; MALE; MEDICAL DECISION MAKING; NEPHROLITHIASIS; OSTEOFLUOROSIS; OSTEOMALACIA; OSTEOSCLEROSIS; REFERENCE VALUE; SYMPTOM; THICKNESS; UNITED STATES;

BIOPSY; BONE DENSITY; CERVICAL VERTEBRAE; FLUORIDE POISONING; FLUORIDES; HUMANS; ILIUM; MALE; MIDDLE AGED; SPINAL CORD DISEASES; TOOTHPASTE;

EID: 33845922672     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.060912     Document Type: Article

References (33)

1. Krishnamachari KA 1986 Skeletal fluorosis in humans: A review of recent progress in the understanding of the disease. Prog Food Nutr Sci 10:279-314.
2. 1997 Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. National Academic Press, Washington, DC, USA.
3. Malde MK, Zerihun L, Julshamn K, Bjorvatn K 2003 Fluoride intake in children living in a high-fluoride area in Ethiopia-intake through beverages. Int J Paediatr Dent 13:27-34.
4. Choubisa SL, Choubisa L, Choubisa DK 2001 Endemic fluorosis in Rajasthan. Indian J Environ Health 43:177-189.
5. Yang L, Peterson PJ, Williams WP, Wang W, Li R, Tan J 2003 Developing environmental health indicators as policy tools for endemic fluorosis management in the People's Republic of China. Environ Geochem Health 25:281-295.
6. Whyte MP, Essmyer K, Gannon FH, Reinus WR 2005 Skeletal fluorosis and instant tea. Am J Med 118:78-82.
7. Browne D, Whelton H, O'Mullane D 2005 Fluoride metabolism and fluorosis. J Dent 33:177-186.
8. Cao J, Zhao Y, Liu J, Xirao R, Danzeng S, Daji D, Yan Y 2003 Brick tea fluoride as a main source of adult fluorosis. Food Chem Toxicol 41:535-542.
9. Kleerekoper M 1996 Fluoride and the skeleton. In: Bilezikian JP, Raisz LG, Rodan GA (eds.) Principles of Bone Biology. Academic Press, San Diego, CA, USA, pp. 1053-1062.
10. Whyte MP, Chines A, Silva DP Jr, Landt Y, Ladenson JH 1996 Creatine kinase brain isoenzyme (BB-CK) presence in serum distinguishes osteopetroses among the sclerosing bone disorders. J Bone Miner Res 11:1438-1443.
11. Shaker JL, Reinus WR, Whyte MP 1998 Hepatitis C-associated osteosclerosis: Late onset after blood transfusion in an elderly woman. J Clin Endocrinol Metab 83:93-98.
12. Christakos S, Favus MJ (eds.) 2003 Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 5th ed. American Society for Bone and Mineral Research, Washington, DC, USA.
13. Boivin G, Chapuy MC, Baud CA, Meunier PJ 1988 Fluoride content in human iliac bone: Results in controls, patients with fluorosis, and osteoporotic patients treated with fluoride. J Bone Miner Res 3:497-502.
14. Whyte MP 2005 Misinterpretation of osteodensitometry with high bone density: BMD Z > or = + 2.5 is not "normal". J Clin Densitom 8:1-6.
15. Roos J, Dumolard A, Bourget S, Grange L, Rousseau A, Gaudin P, Calop J, Juvin R 2005 Osteofluorosis caused by excess use of toothpaste. Presse Med 34:1518-1520.
16. Sjorgren B, Hedstrom L, Lindstedt G 1984 Urinary fluoride concentration as an estimator of welding fume exposure from basic electrodes. Br J Ind Med 41:192-196.
17. Erdal S, Buchanan SN 2005 A quantitative look at fluorosis, fluoride exposure, and intake in children using a health risk assessment approach. Environ Health Perspect 113:111-117.
18. Bentley EM, Ellwood RP, Davies RM 1999 Fluoride ingestion from toothpaste by young children. Br Dent J 186:460-462.
19. Siew Tan B, Razak IA 2005 Fluoride exposure from ingested toothpaste in 4-5-year-old Malaysian children. Community Dent Oral Epidemiol 33:317-325.
20. Colquhoun J 1997 Why I changed my mind about water fluoridation. Perspect Biol Med 41:29-44.
21. Whitford GM 1994 Intake and metabolism of fluoride. Adv Dent Res 8:5-14.
22. Yildiz M, Akdogan M, Tamer N, Oral B 2003 Bone mineral density of the spine and femur in early postmenopausal Turkish women with endemic skeletal fluorosis. Calcif Tissue Int 72:689-693.
23. Riggs BL, Hodgson SF, O'Fallon WM, Chao EY, Wahner HW, Muhs JM, Cedel SL, Melton LJ III 1990 Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 322:802-809.
24. Gruber HE, Baylink DJ 1991 The effects of fluoride on bone. Clin Orthop Relat Res 267:264-277.
25. Lau KH, Baylink DJ 1998 Molecular mechanism of action of fluoride on bone cells. J Bone Miner Res 13:1660-1667.
26. Riggs BL, O'Fallon WM, Lane A, Hodgson SF, Wahner HW, Muhs J, Chao E, Melton LJ III 1994 Clinical trial of fluoride therapy in postmenopausal osteoporotic women: Extended observations and additional analysis. J Bone Miner Res 9:265-275.
27. Kurland ES, Cosman F, Rosen CJ, Lindsay R, Bilezikian JP 2000 Parathyroid hormone (1-34) as a treatment for idiopathic osteoporosis in men: Changes in bone mineral density, bone markers, and optimal duration of therapy. Bone Miner 15(Suppl 1):S230.
28. Talbot JR, Fischer MM, Farley SM, Libanati C, Farley J, Tabuenca A, Baylink DJ 1996 The increase in spinal bone density that occurs in response to fluoride therapy for osteoporosis is not maintained after the therapy is discontinued. Osteoporos Int 6:442-447.
29. Kurland ES, Heller SL, Diamond B, McMahon DJ, Cosman F, Bilezikian JP 2004 The importance of bisphosphonate therapy in maintaining bone mass in men after therapy with teriparatide. Osteoporos Int 15:992-997.
30. Black DM, Bilezikian JP, Ensrud KE, Greenspan SL, Palermo L, Hue T, Lang TF, McGowan JA, Rosen CJ 2005 One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis. N Engl J Med 353:555-565.
31. Frost HM 2003 Bone's mechanostat: A 2003 update. Anat Rec A Discov Mol Cell Evol Biol 275:1081-1101.
32. Frost HM 1987 Bone "mass" and the "mechanostat": A proposal. Anat Rec 219:1-9.
33. Pak CYC, Zerwekh JE, Antich PP, Bell NH, Singer FR 1996 Slow-release sodium fluoride in osteoporosis. J Bone Miner Res 11:561-564.